{"id":197044,"date":"2025-09-03T14:34:15","date_gmt":"2025-09-03T14:34:15","guid":{"rendered":"https:\/\/www.europesays.com\/us\/197044\/"},"modified":"2025-09-03T14:34:15","modified_gmt":"2025-09-03T14:34:15","slug":"common-heart-attack-drug-may-raise-death-risk-in-some-women-study-to-read-more-from-the-study-inshorts-inshorts","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/197044\/","title":{"rendered":"Common heart attack drug may raise death risk in some women: Study | To read more from the study | Inshorts – Inshorts"},"content":{"rendered":"
    \n
  1. Common heart attack drug may raise death risk in some women: Study | To read more from the study | Inshorts<\/a>  Inshorts<\/li>\n
  2. A Common Heart Drug Taken by Millions May Often Be Useless \u2013 or Even Risky<\/a>  ScienceAlert<\/li>\n
  3. Doctors may need to rethink decades of routine beta blocker use for some patients after a heart attack, studies suggest<\/a>  ABC News<\/li>\n
  4. Beta-Blockers Post-MI: A Clear Clinical Message<\/a>  Medscape<\/li>\n
  5. Beta blockers offer no benefit after minor heart attack, trial finds<\/a>  Euronews.com<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"Common heart attack drug may raise death risk in some women: Study | To read more from the…\n","protected":false},"author":3,"featured_media":197045,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[8991,104,53273,3240,106,17407,4446,10000,210,82079,4512,105,728,1060,50,82076,19452,16776,9794,7572,67,132,68,16966,82078,82077,82075],"class_list":{"0":"post-197044","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-attack","9":"tag-breaking-news","10":"tag-common","11":"tag-current-affairs","12":"tag-current-news","13":"tag-daily-news","14":"tag-death","15":"tag-drug","16":"tag-health","17":"tag-health___fitness","18":"tag-heart","19":"tag-latest-news","20":"tag-local-news","21":"tag-medication","22":"tag-news","23":"tag-news-online","24":"tag-raise","25":"tag-risk","26":"tag-some","27":"tag-study","28":"tag-united-states","29":"tag-unitedstates","30":"tag-us","31":"tag-women","32":"tag-82078","33":"tag-82077","34":"tag-82075"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115140865229149754","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/197044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=197044"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/197044\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/197045"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=197044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=197044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=197044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}